Aversi Clinic

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Dermatomyositis and polymyositis (myositis)2 trials
• Migraine1 trial
• Psoriasis1 trial

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial

Lead sponsor

• argenx2 trials
• H. Lundbeck A/S1 trial
• Sun Pharmaceutical Industries Limited1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

  NCT06611163· Phase 3· Sun Pharmaceutical Industries Limited· Source

• Enrolling by invitation

  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

  NCT05979441· Phase 3· argenx· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Dermatomyositis and polymyositis (myositis)1 recruiting

Closed trials

• Completed

  A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

  NCT06323928· Phase 2· H. Lundbeck A/S· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· Phase 2/3· argenx· Source